Picture of Nipro logo

8086 Nipro Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapTurnaround

Momentum

Relative Strength (%)
1m+9.49%
3m-0.52%
6m-7.38%
1yr-8.11%
Volume Change (%)
10d/3m-0.79%
Price vs... (%)
52w High-5.22%
50d MA+0.09%
200d MA+7.49%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)11.93
PEG Ratio (f)1.12
EPS Growth (f)11.95%
Dividend Yield (f)3.05%
Valuation (ttm)IndustryMarket
Price to Book Value0.83
Price to Tang. Book0.97
Price to Free Cashflown/a
Price to Sales0.35
EV to EBITDA9.87

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital3.09%
Return on Equity4.39%
Operating Margin4.02%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue¥m426,399442,516455,559494,789545,199592,073627,4426.64%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-17.51+3.05+73.03-30.76-63.68+130.49+11.95n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Nipro EPS forecast chart

Profile Summary

NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
July 30th, 1948
Public Since
February 1st, 1987
No. of Shareholders
72,385
No. of Employees
38,770
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
163,096,216

8086 Share Price Performance

Upcoming Events for 8086

Full Year 2024 Nipro Corp Earnings Release

Nipro Corp Annual Shareholders Meeting

Q1 2025 Nipro Corp Earnings Release

Similar to 8086

Picture of Alfresa Holdings logo

Alfresa Holdings

jp flag iconTokyo Stock Exchange

Picture of Asahi Intecc Co logo

Asahi Intecc Co

jp flag iconTokyo Stock Exchange

Picture of Aso International logo

Aso International

jp flag iconTokyo Stock Exchange

Picture of As One logo

As One

jp flag iconTokyo Stock Exchange

Picture of Atect logo

Atect

jp flag iconTokyo Stock Exchange

FAQ